Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Fatigue × Methylphenidate × Clear all

Phase

Status

Sponsor Class

OTHER 14 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Therapeutics 4 Counseling 2 exemestane 1 Triptorelin Pamoate 1 Taxes 1 Tamoxifen 1 Reverse Transcriptase Polymerase Chain Reaction 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Polymerase Chain Reaction 1 Paclitaxel 1 Microarray Analysis 1 Methylphenidate 1 Metformin 1 Mental Status and Dementia Tests 1 Interviews as Topic 1 Gonadotropin-Releasing Hormone 1 Gene Expression Profiling 1 Exercise Test 1 Epoetin Alfa 1 Enzyme-Linked Immunosorbent Assay 1 Early Intervention, Educational 1 Dexamethasone 1 Carnitine 1 Carboplatin 1 Brachytherapy 1 Analgesia 1 Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003266 2023-06-18

Methylphenidate in Treating Patients With Melanoma

Eastern Cooperative Oncology Group

Phase 3 Completed

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡